Want to see FR:ALPAT full AI Analyst Report?
ALPAT Stock Chart & Stats
€8.22
€0.00(0.00%)
At close: 4:00 PM EST
€8.22
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€4.58 - €9.50
Previous CloseN/A
Volume10.00
Average Volume (3M)388.00
Market Cap
€6.65M
Enterprise Value€10.45M
Total Cash (Recent Filing)€669.00K
Total Debt (Recent Filing)€5.97M
Price to Earnings (P/E)11.6
Beta0.20
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,132,326
10 Day Avg. Volume379
30 Day Avg. Volume388
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)1.44
Price to Sales (P/S)6.86
P/FCF Ratio6.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Return To ProfitabilityA return to material profitability and a ~48% net margin in 2024 indicates the business can generate economic profit at current scale. Durable profits improve reinvestment capacity for R&D/commercialization, support creditor confidence, and reduce reliance on dilutive financing if maintained.
Positive Cash GenerationSustained positive operating and free cash flow strengthens liquidity and funds operations or growth without external capital. For a small biotech, this materially lowers refinancing risk, enables incremental product development or commercialization spending, and supports smoother operations over months.
Improved Leverage And ReturnsMeaningful reduction in leverage and a positive ROE improve solvency and financial flexibility. Lower leverage reduces interest burden and covenant pressure, enabling management to pursue strategic partnerships or capex with less dilution risk and a stronger balance sheet cushion.
Bears Say
Small, Volatile Revenue BaseA small and volatile revenue base undermines the durability of margins and cash flow; sharp swings (deep declines in prior years and a modest rebound) increase execution risk, limit scale economies, and make multi-quarter forecasting and reinvestment planning more uncertain.
Short Track Record Of Positive ResultsWhile 2024 improved, prior multi-year losses and intermittent negative cash flow indicate limited consistency. A short track record of profitability raises the chance that recent gains are cyclical, making long-term capital allocation and product commercialization riskier until multi-year stability is demonstrated.
Material Absolute Debt For SizeDespite improved leverage ratios, absolute debt remains material relative to a small revenue base. This can constrain R&D or commercialization spending, increase refinancing risk if revenue dips, and leave less room to absorb setbacks without resorting to dilutive or costly external financing.
Plant Advanced Technologies SA News
ALPAT FAQ
What was Plant Advanced Technologies SA’s price range in the past 12 months?
Plant Advanced Technologies SA lowest stock price was €4.58 and its highest was €9.50 in the past 12 months.
What is Plant Advanced Technologies SA’s market cap?
Plant Advanced Technologies SA’s market cap is €6.65M.
When is Plant Advanced Technologies SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Plant Advanced Technologies SA’s earnings last quarter?
Currently, no data Available
Is Plant Advanced Technologies SA overvalued?
According to Wall Street analysts Plant Advanced Technologies SA’s price is currently Overvalued.
Does Plant Advanced Technologies SA pay dividends?
Plant Advanced Technologies SA does not currently pay dividends.
What is Plant Advanced Technologies SA’s EPS estimate?
Plant Advanced Technologies SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Plant Advanced Technologies SA have?
Plant Advanced Technologies SA has 1,132,326 shares outstanding.
What happened to Plant Advanced Technologies SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Plant Advanced Technologies SA?
Currently, no hedge funds are holding shares in FR:ALPAT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Plant Advanced Technologies SA
Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce your exclusive, personalized Exudactive; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. Plant Advanced Technologies SA was incorporated in 2005 and is headquartered in Vandœuvre-lès-Nancy, France.